Company

Grid Therapeutics

Biotechnology Research Durham, North Carolina, United States 4 employees

Employees: 4
Contacts: 3
Emails: 3

gridtherapeutics.com LinkedIn Crunchbase

Grid Therapeutics Overview

Headquarters: Durham, North Carolina, United States
Phone Number: Available in AeroLeads
Website: gridtherapeutics.com
Industry: Biotechnology Research
Employees: 4
Founded: 2014
Funding: 5.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Grid Therapeutics

Grid Therapeutics is a biotech company based on the innovative science first developed by Edward F. Patz, Jr. MD and his team of scientists at Duke University Medical Center. Located in Durham, North Carolina, Grid is developing the first human derived targeted immunotherapy for cancer. The antibody was discovered in exceptional outcome early stage lung cancer patients who did not progress to develop metastasis. The antibody was isolated from patient’s B-cells using state of the art molecular genomic techniques. “GT103”, the company’s lead asset, is currently enrolling the first-in-man Phase 1 clinical trial in refractory NSCLC patients.

Grid Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage

Grid Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Edward (Ned) Patz	Chief Executive Officer at Grid	Chapel Hill, North Carolina, United States	Email
Ryan D.	Clinical Sciences and Operations	Charleston County, South Carolina, United States	Email
Michael Campa		Durham, North Carolina, United States	Email